Nurix Therapeutics Inc.

09/12/2024 | Press release | Distributed by Public on 09/12/2024 22:26

Nurix Therapeutics Presents New Positive Data from Phase 1a/1b Clinical Trial of NX-5948 in Chronic Lymphocytic Leukemia at the 66th American Society of Hematology Annual Meeting

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.